---
schema_version: "secwatch.filing_event.v1"
accession: "0001808665-24-000033"
form_type: "8-K"
ticker: "ASRT"
cik: "0001808665"
company_name: "Assertio Holdings, Inc."
filed_at: "2024-08-07T23:59:59+00:00"
generated_at: "2026-05-31T11:51:35.177967+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Assertio Q2 net product sales $30.7M, GAAP net loss $3.7M; reiterates FY guidance

## Summary
- Net product sales $30.7M vs $40.1M in Q2 2023; GAAP net loss $0.04/share vs income $0.13/share.
- Rolvedon net sales $15.1M, up from $14.5M QoQ; Indocin $6.9M, down from $8.7M due to generic competition.
- Adjusted EBITDA $5.0M vs $24.8M in Q2 2023; cash from operations $7.4M.
- Cash & short-term investments $88.4M, up from $80.7M; debt $40.0M in 6.5% convertible notes due 2027.
- FY 2024 guidance reaffirmed: net product sales $110-125M, adjusted EBITDA $20-30M.

## SEC filing metadata
- accession: 0001808665-24-000033
- form_type: 8-K
- ticker: ASRT
- cik: 0001808665
- company_name: Assertio Holdings, Inc.
- filed_at: 2024-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808665/000180866524000033/0001808665-24-000033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808665/000180866524000033/asrt-20240807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001808665-24-000033
- JSON: https://secwatch.observer/filing/0001808665-24-000033.json
- Plain text: https://secwatch.observer/filing/0001808665-24-000033.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.